Retatrutide is a research peptide investigated as a triple agonist targeting GLP-1, GIP, and glucagon receptors. Supplied as lyophilized powder of pharmaceutical grade purity for in vitro research applications.

SPECIFICATIONS:
- Purity: 99.6%
- Molecular Weight: 4731.30 g/mol
- Sequence: Modified GLP-1/GIP/Glucagon triple agonist analogue
- Format: Lyophilized powder
- Size: 10mg per vial

STORAGE INSTRUCTIONS:
Lyophilized: Store at -20°C
Reconstituted: Store at 2–8°C for up to 30 days

RECONSTITUTION PROTOCOL:
Reconstitute with 2mL bacteriostatic water. Typical research aliquots: 0.25–0.5mg.

RESEARCH USE NOTES:
Investigated in research models studying metabolic regulation, energy expenditure pathways, and receptor agonism.

✓ HPLC Tested
✓ High Purity 99.6%+
✓ GMP Manufacturing
✓ COA Available
✓ Cold-Chain Shipped

⚠️ FOR RESEARCH USE ONLY — Not for human consumption, veterinary use, or therapeutic application. Products are sold strictly for in vitro laboratory research purposes.